Kara Long Roche, MD, MSc, FACOG
Gynecologic Surgeon
My Role at MSKWe post reviews for MSK healthcare providers who have at least 30 patient experience surveys completed. If you do not see reviews for a provider, it may be because they do not yet have enough survey responses, or the provider may not be part of the group of healthcare providers included in the survey.
Only outpatient providers are included in the survey. Healthcare providers who only work in the hospital or in urgent care are not included in the survey. Pathologists or researchers who do not provide direct care to patients do not have reviews.
Areas of Expertise
My Specialties
- Ovarian Cancer
- Uterine (Endometrial) Cancer
- Cervical Cancer
About Me
- Associate Director, Gynecologic Oncology Fellowship Program
- Section, Ovarian Cancer Surgery
I am a gynecologic oncologist who is dedicated to improving the lives of women with gynecologic cancers. These include ovarian cancer, uterine cancer, cervical cancer, and vulvar cancer. I am also committed to developing better ways to screen for and prevent gynecologic cancers in women who are at higher risk for these diseases.
I perform surgeries at Memorial Hospital and Josie Robertson Surgery Center in Manhattan, and see patients at Rockefeller Outpatient Clinic, also in Manhattan, and MSK Basking Ridge, in New Jersey.
Read more
I am a daughter, mother, and wife who has been personally impacted by ovarian cancer. I understand the burden it can place on a woman’s entire life. My experiences not only affirm my career choice but also fuel my determination and passion in the operating room, and guide the way I develop relationships with each of my patients and their families.
At MSK, I am part of a team of surgeons that is clinically and scientifically committed to and passionate about treating ovarian cancer. Because of our streamlined focus and close collaboration, we are able to offer some of the best outcomes in the world for women with this disease. I perform about 250 gynecologic procedures each year, using minimally invasive techniques when appropriate so that women can get back to their lives more quickly after surgery. In addition, I am skilled at performing cytoreductive surgery, which means I remove all visible disease so that the cancer is more susceptible to chemotherapy. For women who want to start or grow their families, I perform fertility-preserving surgical procedures whenever possible.
One of my biggest focuses in and out of the operating room is helping women who are at high risk for developing a gynecologic cancer. I have extensive experience in performing risk-reduction surgery and am currently working with my colleagues to develop new strategies to improve this procedure. I am also researching the development of novel screening and early detection techniques with the goal of reducing the number of women who are impacted by gynecologic cancers.
Women who are diagnosed with a gynecologic cancer often take on a tremendous amount of information, stress, and added responsibility on top of their already busy lives. As their surgeon, I hope my patients feel confident and reassured that they have someone on their side who will help take on some of this burden.
I am running the New York City Marathon as part of Fred’s Team to raise money for cancer research at MSK. If you would like to donate or learn more about Fred’s Team, please visit my page.
A gynecologic (GY-neh-kuh-LAH-jik) surgeon is a doctor with special training in surgery on the female reproductive system. This includes the cervix, endometrium, fallopian tubes, ovaries, uterus, and vagina.
My Specialties
- Ovarian Cancer
- Uterine (Endometrial) Cancer
- Cervical Cancer
- Vulvar Cancer
- Cytoreductive Surgery and Peritonectomy Procedures
- Minimally Invasive Procedures (Laparoscopic and Robotic)
- Prevention of Ovarian and Endometrial Cancer in High-Risk Women
- Fertility Sparing-Surgery
Education
- MS, Cornell University
- MD, University of North Carolina
Residencies
- Obstetrics and Gynecology - New York University Medical Center
Awards and Honors
- Michael E. Burt MD, PhD Award for Superior Clinical & Operative Skills, Department of Surgery, Memorial Sloan Kettering
- Award for Excellence in Teaching & Mentorship, Johns Hopkins Hospital
Fellowships
- Gynecologic Oncology - Memorial Sloan Kettering Cancer Center
Board Certifications
- Obstetrics and Gynecology
- Gynecologic Oncology
Insurance Information
Understanding your insurance options is an important part of managing your cancer care. We have relationships with many common healthcare providers and plans.
In Network Coverage Type
PPO, POS, EPO, HMO
In Network Coverage Type
PPO, HMO, DSN
In Network Coverage Type
HMO, PPO
In Network Coverage Type
HMO, EPO PPO, POS
In Network Coverage Type
PPO, POS, EPO, HMO
Offers a qualified health plan from the Health Insurance Marketplace. Call Emblem to learn more.
In Network Coverage Type
PPO, HMO
In Network Coverage Type
PPO
In Network Coverage Type
HMO, EPO
Offers a qualified health plan from the Health Insurance Marketplace. Call Fidelis to learn more.
In Network Coverage Type
EPO, HMO, PPO, POS
Offers a qualified health plan from the Health Insurance Marketplace. Call Healthfirst to learn more.
In Network Coverage Type
HMO
In Network Coverage Type
PPO
In Network Coverage Type
EPO
In Network Coverage Type
EPO
In Network Coverage Type
Federal Government
In Network Coverage Type
PPO, POS, EPO, HMO
In Network Coverage Type
State Government
Don't see your carrier or plan? We can help you understand your coverage.
If you don't have health insurance or are worried that your care may not be fully covered, our financial assistance programs may be able to help.
If you have questions about insurance, call us at 646-497-9176.
Make an Appointment
Contact and Location
Dr. Long Roche sees patients at two locations.
Looking to see a doctor at a different location? See all MSK locations.
Colleagues
Doctors at Memorial Sloan Kettering work as teams, with specialists from all different areas. This allows us to consider all your needs together, and to give you the best possible care.
Clinical Trials
- Clinical Trials Co-Investigated by Dr. Long Roche
- A Phase 2 Study of IMNN-001 on Second-Look Surgery in Combination With Bevacizumab and Chemotherapy in People Newly Diagnosed With Ovarian, Fallopian Tube, or Primary Peritoneal Cancers
Memorial Sloan Kettering's doctors and scientists are constantly developing new treatments for cancer. MSK is typically running hundreds of clinical trials at a given time.
You may be able to participate in a clinical trial even if you are new to MSK. Search our online directory to find trial information and see more about who can participate.
Search clinical trialsResearch and Publications
Visit PubMed for a full listing of Dr. Long Roche’s journal articles. Pubmed is an online index of research papers and other articles from the US National Library of Medicine and the National Institutes of Health.
See all on PubMedPatient Reviews
Your trust is our main concern
We strive to keep reviews trustworthy, honest and fair. Learn more about our patient experience reviews.
Disclosures
Doctors and faculty members often work with pharmaceutical, device, biotechnology, and life sciences companies, and other organizations outside of MSK, to find safe and effective cancer treatments, to improve patient care, and to educate the health care community.
MSK requires doctors and faculty members to report (“disclose”) the relationships and financial interests they have with external entities. As a commitment to transparency with our community, we make that information available to the public.
Kara Long Roche discloses the following relationships and financial interests:
No disclosures meeting criteria for time period
If you’re a patient at MSK and would like more information about your doctor’s external relationships, please talk with your doctor.
The information published here is a complement to other publicly reported data and is for a specific annual disclosure period. There may be differences between information on this and other public sites as a result of different reporting periods and/or the various ways relationships and financial interests are categorized by organizations that publish such data.
This page and data include information for a specific MSK annual disclosure period (January 1, 2023 through disclosure submission in spring 2024). This data reflects interests that may or may not still exist. This data is updated annually.
Learn more about MSK’s COI policies here. For questions regarding MSK’s COI-related policies and procedures, email MSK’s Compliance Office at [email protected].